Momentum is continuing for biosimilars switching programs in Canada, with Prince Edward Island – the smallest Canadian province in terms of geographical size and population – becoming the 11th Canadian province or territory to introduce such an initiative.
The move builds on a succession of Canadian jurisdictions to have introduced biosimilar switching schemes, starting from British Columbia in...






